186 related articles for article (PubMed ID: 15451338)
1. Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone.
Mirkin S; Archer DF
Contraception; 2004 Oct; 70(4):327-33. PubMed ID: 15451338
[TBL] [Abstract][Full Text] [Related]
2. Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cells.
Mirkin S; Mahony MC; Archer DF
Menopause; 2004; 11(1):82-8. PubMed ID: 14716187
[TBL] [Abstract][Full Text] [Related]
3. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
4. Hormone therapy and endometrial angiogenesis.
Mirkin S; Navarro F; Archer DF
Climacteric; 2003 Dec; 6(4):273-7. PubMed ID: 15006248
[TBL] [Abstract][Full Text] [Related]
5. Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, progesterone, and 17beta-estradiol on thrombospondin-1 mRNA in Ishikawa cells.
Mirkin S; Archer DF
Fertil Steril; 2004 Jul; 82(1):220-2. PubMed ID: 15237017
[TBL] [Abstract][Full Text] [Related]
6. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
[TBL] [Abstract][Full Text] [Related]
7. Effect of raloxifene, 17beta-estradiol, and progesterone on mRNA for vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 in Ishikawa cells.
Navarro FJ; Mirkin S; Archer DF
Fertil Steril; 2003 Jun; 79(6):1409-15. PubMed ID: 12798890
[TBL] [Abstract][Full Text] [Related]
8. Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Int J Gynecol Cancer; 2006; 16 Suppl 2():560-3. PubMed ID: 17010073
[TBL] [Abstract][Full Text] [Related]
9. Progesterone induces the expression of vascular endothelial growth factor (VEGF) 120 and Flk-1, its receptor, in bovine granulosa cells.
Shimizu T; Miyamoto A
Anim Reprod Sci; 2007 Dec; 102(3-4):228-37. PubMed ID: 17275223
[TBL] [Abstract][Full Text] [Related]
10. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
[TBL] [Abstract][Full Text] [Related]
11. [Expression of vascular endothelial growth factor and thrombospondin-1 in the ectopic and eutopic endometrium of women with endometriosis].
Tan X; Lang J; Liu D
Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):727-30. PubMed ID: 16136892
[TBL] [Abstract][Full Text] [Related]
12. Effect of mifepristone on uterine receptivity in guinea pigs.
Liu CQ; Wang ZX; Yuan Y
Acta Pharmacol Sin; 2002 Feb; 23(2):177-82. PubMed ID: 11866881
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines.
Navo MA; Smith JA; Gaikwad A; Burke T; Brown J; Ramondetta LM
Cancer Chemother Pharmacol; 2008 Aug; 62(3):483-9. PubMed ID: 18004570
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of damaged endometrial stromal cells model in vitro].
Yang XQ; Zhang M; Zhang YQ; Tang XJ; Li W; Xu YZ; Yang B
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):274-80. PubMed ID: 22781114
[TBL] [Abstract][Full Text] [Related]
15. Mifepristone-induced amenorrhoea is associated with an increase in microvessel density and glucocorticoid receptor and a decrease in stromal vascular endothelial growth factor.
Narvekar N; Critchley HO; Cheng L; Baird DT
Hum Reprod; 2006 Sep; 21(9):2312-8. PubMed ID: 16807278
[TBL] [Abstract][Full Text] [Related]
16. Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.
Meng CX; Andersson KL; Bentin-Ley U; Gemzell-Danielsson K; Lalitkumar PG
Fertil Steril; 2009 Jan; 91(1):256-64. PubMed ID: 18206148
[TBL] [Abstract][Full Text] [Related]
17. [Effect of estrogen and progesterone on the expression of VEGF mRNA in epithelial ovarian cancer cell line].
Li H; Sun H
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):264-7. PubMed ID: 15312358
[TBL] [Abstract][Full Text] [Related]
18. Intra-amniotic infection upregulates decidual cell vascular endothelial growth factor (VEGF) and neuropilin-1 and -2 expression: implications for infection-related preterm birth.
Snegovskikh VV; Schatz F; Arcuri F; Toti P; Kayisli UA; Murk W; Guoyang Luo ; Lockwood CJ; Norwitz ER
Reprod Sci; 2009 Aug; 16(8):767-80. PubMed ID: 19474288
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids.
Iwai A; Fujii Y; Kawakami S; Takazawa R; Kageyama Y; Yoshida MA; Kihara K
Mol Cell Endocrinol; 2004 Oct; 226(1-2):11-7. PubMed ID: 15489000
[TBL] [Abstract][Full Text] [Related]
20. Changes in vaginal morphology, steroid receptor and natural antimicrobial content following treatment with low-dose mifepristone.
Narvekar N; Lakha F; Critchley HO; Glasier AF; Williams AR; Leminen R; Heikinheimo O; Kelly RW; Baird DT
Contraception; 2007 Apr; 75(4):271-80. PubMed ID: 17362705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
